Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Take Compensation Pieces Out Of Stark Law, Legal Experts Tell Senators

Executive Summary

Legal experts and a hospital CEO agreed at a Senate Finance Committee hearing that getting rid of the compensation components of the Stark Law barring physician self-referrals – while keeping in the ownership restrictions – may be the best way to protect patients from overuse of medical services while promoting value-based payment systems.

You may also be interested in...

CMS Asks How To Ease Burdens Of US Physician Self-Referral Law

The US Center for Medicare and Medicaid Services launched a request seeking information from the public on how to reduce burdens of the physician self-referral “Stark Law,” which is intended to prevent physicians from enriching themselves with referrals, but has challenged health-care organizations, particularly those participating in accountable care organizations (ACOs), for several years.

Anti-Kickback Reforms Urged To Support Outcomes-Based System

AdvaMed wants more safe harbors around product warranties and rebates, while the Healthcare Leadership Council is asking for protections for health records software and manufacturer giveaways.

Senate Finance Hearing To Focus Stark Self-Referral Law Exceptions

The Senate Finance Committee plans to debate potential reforms and exceptions to the Stark self-referral law for health-care companies and physicians on July 12 to make the statute better support alternative Medicare payment models. And the committee has released a white paper on the topic.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts